Why a British hospital, and not a drugmaker, is trying to get a rare disease therapy approved
Why a British hospital, and not a drugmaker, is trying to get a rare disease therapy approved.
Why a British hospital, and not a drugmaker, is trying to get a rare disease therapy approved.
CVS Health missed its Q1 projections and lowered its full-year outlook, citing medical cost hikes with Medicare Advantage patients. Its stock price slid.
USC researcher Hangbo Zhao has published a series of papers on stretchable sensors for biomedical purposes. His most recent paper, selected as the cover story for…
More people across the United States – nearly 40% – live in places with unhealthy levels of polluted air, according to a new report from…
The Xist RNA protein complex, present only in females, is immunogenic and may underlie female-biased autoimmunity.
This study investigates how pregnancy and motherhood affect women journalists of the past and present. A mixed method approach of oral histories and qualitative…
It’s no secret that working out is good for your health, but now, a new study is showing how it can save your life.
For some older adults, a rural setting in late life may be protective
As student-led uprisings and protests grow across the country and around the world, the American Medical Student Association (AMSA) reaffirms its
The DEA is allowing annual and semi-annual production quotas for Schedule II drugs, after it became clear quarterly quotas would worsen shortages.